Skip to Main Content

Paper Details

Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals.
J Antimicrob Chemother
4
2020
Author NameAffiliation
Sebastian Schneeweiss
Sebastian SchneeweissDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, and Harvard Medical School
Melissa SaulUniversity of Pittsburgh, and University of Pittsburgh Medical Center
Shmuel ShohamJohns Hopkins University School of Medicine
Fernanda P SilveiraUniversity of Pittsburgh, and University of Pittsburgh Medical Center
Alexander M Walker
  • 1 - 6

Datasets

Release 1.2